Medvi is one of the cheapest GLP-1 options available, while Shed charges more and adds four medication formats and a 120-day money-back guarantee if you do not lose 5% of your weight, subject to eligibility, required check-ins and adherence to the program. This comparison helps you decide if the guarantee is worth the premium.
Platform Overview
Medvi is an ultra-budget GLP-1 telehealth platform charging $197-$247 per month, targeting cost-sensitive patients who prioritize low-cost medication access over full support. The platform's model is deliberately lean: patients receive a prescription and basic clinical oversight, but intensive coaching and behavioral programming are not central features. Medvi appeals to self-directed patients who have researched GLP-1 medications, understand the treatment protocol, and primarily need a licensed prescribing pathway rather than extensive guidance. The tradeoff for the lower price is a more transactional clinical experience. FDA-approved GLP-1 treatment protocols that Medvi follows require medical oversight regardless of platform pricing tier.
Shed positions itself at a higher value tier than Medvi at $199-$499 per month, adding dedicated weight loss coaching and a 120-day refund term if you do not lose 5% of your weight, with eligibility, check-in and adherence conditions. Shed's model recognizes that medication alone produces suboptimal results for many patients - a finding supported by behavioral support research published in JAMA. For patients who are uncertain whether they have the self-motivation to sustain GLP-1 adherence without structured support, Shed's coaching infrastructure provides a meaningful safety net.
Pricing Comparison
Medvi's $197-$247 per month pricing is among the lowest in the GLP-1 telehealth market, making it accessible to patients for whom cost is the primary barrier. At this price point, Medvi is delivering medication management at near-commodity pricing, which is a genuine service to patients who cannot afford higher-priced platforms. The cost savings are real, but the absence of broad coaching and a refund term means you absorb more of the behavioral and financial risk yourself. For highly self-motivated patients who will research and implement lifestyle modifications independently, Medvi's pricing can be the right economic choice.
NIH weight management guidance acknowledges cost as a significant access barrier.
Shed's $199-$499 per month pricing sits modestly above Medvi's floor, but the value differential is substantial. Shed's 120-day money-back guarantee if you do not lose 5% of your weight, subject to eligibility, required check-ins and adherence to the program gives you a refund path that Medvi's no-guarantee model does not. For patients with a history of weight loss attempts, the modest premium at Shed may be a more rational investment when the outcome protection is factored into the calculation. The
CDC confirms that supported programs produce better long-term results than self-directed approaches.
Medication Options and Quality
Medvi offers semaglutide and, depending on availability, tirzepatide through compounding pharmacy channels. At its price point, Medvi is focused on efficient prescription delivery rather than premium pharmacy partnerships. The platform's compounding pharmacy sourcing should be verified by patients who have concerns about compound quality, as not all FDA-registered compounders operate at equivalent quality standards. Medvi's lean model means pharmacy oversight is primarily handled through compliance rather than active quality monitoring programs.
NEJM semaglutide trial data shows strong efficacy when medication quality is maintained, making pharmacy sourcing a critical evaluation point for budget platform patients.
Shed provides semaglutide and tirzepatide through licensed compounding pharmacies, with the platform's clinical team actively managing medication quality and dosing as part of the overall program. Tirzepatide's superior efficacy - with
NEJM data showing 20%+ average weight loss - is available to qualifying patients. Shed's medication management is integrated with its coaching program, meaning dose adjustments are coordinated with behavioral support rather than handled in isolation. This integration ensures patients receive appropriate guidance during the challenging early titration phase.
Medical Team and Support
Medvi provides licensed medical oversight for prescription decisions and safety monitoring, meeting the baseline clinical requirements for GLP-1 prescribing. However, the platform's minimal support model means patients should not expect intensive coaching, frequent check-ins, or proactive provider outreach. Medvi is designed for patients who are essentially managing their own weight loss journey and using the platform primarily for legal access to medication. This model can work well for patients with prior GLP-1 experience who understand titration and side effect management, but it is less appropriate for first-time GLP-1 users who may need more guidance. JAMA behavioral research consistently shows support intensity correlates with better outcomes.
Shed's medical support model includes licensed prescribers supported by weight loss coaches who provide the ongoing behavioral infrastructure that distinguishes the platform from minimal-support options like Medvi. Coaches at Shed are trained in weight loss-specific behavioral techniques and proactively check in during high-risk phases of the program. The
American Association of Clinical Endocrinology recommends combined pharmacological and behavioral treatment as the evidence-based standard for obesity management - a recommendation that Shed implements and Medvi largely does not.
Weight Loss Approach and Programs
Medvi's weight loss approach is medication-centric by design. The platform provides GLP-1 prescriptions, basic dosing guidance, and clinical safety monitoring, leaving the broader program design to the patient. This is not inherently problematic for all patients - those with strong self-direction, prior GLP-1 familiarity, or access to their own nutrition and fitness resources can achieve good results on Medvi. Patients who need structure, accountability, and guidance to optimize their program should recognize that Medvi's model requires them to supply those elements themselves.
Shed's approach integrates pharmacotherapy with structured coaching and adds a conditional 120-day money-back guarantee (lose 5% of your weight or get a refund, subject to eligibility and program adherence). Every element of the patient experience is designed to produce measurable outcomes within the program timeline. Coaches work with patients on nutritional habits, physical activity, adherence challenges, and motivation - the full behavioral stack that medication alone cannot address.
User Experience and Satisfaction
Medvi's user experience reflects its budget positioning: functional, efficient, and unembellished. The platform handles prescription management and refills reliably, and patients who know what they want and need minimal hand-holding report satisfaction with the streamlined process. Patients who expect coaching, regular check-ins, or a rich program experience report disappointment, suggesting that expectation alignment is critical for Medvi satisfaction. The platform's low cost attracts a large volume of self-directed users, and community forums among GLP-1 users often include Medvi customers sharing their self-managed experiences. Patients should research independent reviews carefully before committing.
Shed's member portal is purpose-built for GLP-1 weight loss program management, with coaching touchpoints and progress tracking integrated throughout. Users describe the coaching team as genuinely engaged rather than perfunctory, and the proactive check-in model means patients feel supported during the inevitable challenging periods of GLP-1 therapy. The
NIH's research on adherence confirms that patients with stronger provider relationships maintain GLP-1 treatment more consistently.
How We Compared Medvi vs Shed
Our Comparison Methodology
This comparison is based on analysis of pricing structures and service models from both platforms.
Clinical Evidence: Weight loss treatment recommendations reference FDA-approved GLP-1 medication information (FDA Wegovy Label) and clinical efficacy data from The New England Journal of Medicine.
Pricing Analysis: Pricing reflects the rates last recorded in our provider database; providers change prices frequently, so confirm current pricing directly at checkout.
Service Verification: Platform capabilities, provider credentials, and service quality were evaluated through detailed review of service offerings.
How we get paid, plainly: most providers on this page pay ManyTreatments an affiliate commission when you buy through our links. No provider buys a position, a rating, or a listing here. We stop short of telling you commissions have never shaped anything on this site, since we cannot put evidence for that in front of you. Our goal is to provide evidence-based comparison to help you make informed weight loss treatment decisions.
Final Verdict: Medvi vs Shed
Choose Medvi if: You are a highly self-directed patient with prior GLP-1 experience who primarily needs an affordable, legitimate prescribing channel and does not require coaching or behavioral support. Medvi's ultra-budget pricing makes GLP-1 access possible for cost-constrained patients who can manage their own program.
Choose Shed if: You want a structured weight loss program with coaching and a conditional money-back guarantee. Shed's 120-day money-back guarantee if you do not lose 5% of your weight, subject to eligibility, required check-ins and adherence to the program and coaching may be worth the premium over Medvi if you are new to GLP-1 treatment or have had setbacks before.
Bottom line: Medvi and Shed represent opposite ends of the GLP-1 telehealth support spectrum. Medvi is medication access at minimum cost; Shed is a program built around coaching and a conditional 120-day refund policy tied to losing 5% of your weight. If you want structured support, Shed's combination of coaching and its refund guarantee makes it the stronger investment despite the higher price - though individual results vary with any program.
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
